News

Newsletter

Brazilian Data Protection Office’s website is on

Although it was created in July 2019, the Brazilian Data Protection Office (ANPD) has started to show its operationalization. Two months after the presidential decree setting forth its regimental structure and one month after the appointment of its Board of Directors, the ANPD’s official website was made available yesterday, December 7th, 2020 (www.gov.br/anpd/pt-br).
 
The website is simple and intuitive and offers the communication channels from the Office of the Comptroller General’s ombudsman and information access. The user can file a complaint, compliment or suggest debureaucratization measures and public service improvements. Information from the Federal Public Administration can also be requested using the same channels. The ANPD itself is not yet listed as one of the entities to which the user can address his request. 
 
Considering that the administrative sanctions brought by the LGPD are applicable as of August 1st, 2021, the ANPD’s website is expected to be improved in the coming months. Such improvements are important in the sense of enabling the direct and easier contact with data subjects and civil entities, as well as simplifying the access to the LGPD’s guidelines and regulations.
 
If you want to receive more information about the LGPD, strategies for compliance or trends in the Brazilian and the international scenario, our team specialized in Digital Law is available at digital@kasznarleonardos.com.
Back

Last related news

September 6, 2022

Brazilian National Health Surveillance Agency authorizes exceptional drug and vaccine use against Monkeypox by the Ministry of Health

The Ministry of Health (MH) sent Brazilian National Health Surveillance Agency (Anvisa) a request for exemption from the sanitary registration, on an Brazilian National Health Surveillance Agency authorizes exceptional drug and vaccine use against Monkeypox by the Ministry of Health

Ler notícia

August 16, 2022

Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

On August 8th, 2022, during the 12th Extraordinary Public Meeting of DICOL, ANVISA’s Collegiate Board of Directors announced the completion of the toxicological Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

Ler notícia

July 19, 2022

Carbendazim toxicological revaluation about to be completed by ANVISA

In December 2019, ANVISA started the process of toxicological revaluation of the Active Ingredient (AI) Carbendazim, as signs of toxicity were identified Carbendazim toxicological revaluation about to be completed by ANVISA

Ler notícia